Stock screener

RIGL

Conviction 72HealthcareScan · Thu, Sep 24, 2026

Rigel Pharmaceuticals Inc (RIGL) closed at $47.81 (-0.66%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 59, RS Rating 93, -6.2% from its 52-week high, +14.3% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

RIGL$47.81-0.66%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 269.43K
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
RIGEL PHARMACEUTICALS INCPHARMACEUTICAL PREPARATIONSwww.rigel.com ↗
Price47.81
Change-0.66%
Gap+0.44%
Rel volume—
Avg volume252.59K
Avg $ vol11.85M
SMA 2047.06
SMA 5043.42
SMA 20036.35
Price vs 50+10.11%
Price vs 200+31.51%
MA stackbullish
50/200 cross—
Supertrendup · 43.39
RSI (14)59
MACD hist-0.10
MACD cross—
Stoch %K / %D77 / 77
ADX (14)26
+DI / −DI26 / 16
RSI divergenceBearish
MACD divergenceBearish
ATR %3.57%
ADR %3.19%
52w high50.96
52w low25.44
From 52w high-6.18%
Above 52w low+87.93%
New 52w highNo
SqueezeOff
Bollinger width11.26%
%B0.64
Donchian pos65.85%
Donchian high49.90
Donchian low43.78
AVWAP (52w high)36.83
vs AVWAP high+29.81%
AVWAP (52w low)35.60
vs AVWAP low+34.29%
OBV trendFlat
Chaikin MF (20)0.21
Today vs 20d—
Avg vol (14d)269.43K
Avg vol (20d)252.59K
Avg $ vol (20d)11.85M
Market cap893.08M
RS Rating93 / 99
RS 3m (vs SPY)+24.76%
RS 6m (vs SPY)+65.04%
RS line new highNo
Trend template6/8
Technical rank92.8
1 week+4.27%
1 month+2.27%
3 months+29.25%
6 months+81.86%
1 year+40.53%
YTD+14.30%
P/E2.43
P/B2.10
P/S3.03
P/FCF11.88
EPS19.48
Div yield—
ROE86.27%
ROA70.44%
Debt/Eq0.11
Current1.94
EV/EBITDA6.86
Gross margin5.92%
Net margin124.72%
Rev growth64.15%
EPS growth1999.08%
Price target65.00
Target upside35.95%
Analyst ratingBuy
Institutional94.90%
Ent. value877.27M
Revenue78.7M
Net income17.29M
Gross profit—
Free cash flow75.2M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out18.5M
Employees174
ListedWed, Nov 29, 2000
Free float16.56M
Float %89.5%
Short interest3.18M
Days to cover9.1d
Short volume73.4%
Squeeze score83 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.88 vs $0.91
Last surprise-3.3% miss
Setup gradeB
Conviction72 / 100
Pattern quality—
Tech rank92.8 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance49.46
Support42.05
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in RIGL

All disclosures →
No recent disclosed trades by Congress in RIGL. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in RIGL · open-market 1 sell

InsiderSideShares
HANNAH ALISON L.
EVP, Chief Medical Officer · Common Stock · 2026-07-08
Grant24.4K
Ali-Jackson Kamil
Director · Common Stock · 2026-06-22
Sell2.5K
Schorno Dean L
EVP & Chief Financial Officer · Employee Stock Option (right to buy) · 2026-06-17
Grant7.39K
Furey Raymond J.
EVP, GC, CCO & Corp Sec · Employee Stock Option (right to buy) · 2026-06-17
Grant7.39K
Santos David A
EVP, Chief Commercial Officer · Employee Stock Option (right to buy) · 2026-06-17
Grant7.39K
RODRIGUEZ RAUL R
CEO, President · Employee Stock Option (right to buy) · 2026-06-17
Grant31.7K
Rojkjaer Lisa
EVP, Chief Medical Officer · Employee Stock Option (right to buy) · 2026-06-17
Grant9.38K
Rojkjaer Lisa
EVP, Chief Medical Officer · Employee Stock Option (right to buy) · 2026-06-17
Grant7.39K
RODRIGUEZ RAUL R
CEO, President · Common Stock · 2026-06-01
Tax2.42K
Schorno Dean L
EVP & Chief Financial Officer · Common Stock · 2026-06-01
Exercise1.2K

SEC filings

EDGAR filings in RIGL · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.